Drug Shortage Report for ETHACRYNATE SODIUM FOR INJECTION USP
| Report ID | 218436 |
| Drug Identification Number | 02469456 |
| Brand name | ETHACRYNATE SODIUM FOR INJECTION USP |
| Common or Proper name | ETHACRYNATE SODIUM FOR INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHACRYNIC ACID |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 VIAL |
| ATC code | C03CC |
| ATC description | HIGH-CEILING DIURETICS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2023-11-30 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-02-05 |
| Company comments | VPI Ethacrynate Sodium is available at 75% allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-02-05 | French | Compare |
| v1 | 2024-02-05 | English | Compare |
Showing 1 to 2 of 2